Abstract

Genetic testing plays an increasing diagnostic and prognostic role in the management of patients with heritable thoracic aortic disease (HTAD). The identification of a specific variant can establish or confirm the diagnosis of syndromic HTAD, dictate extensive evaluation of the arterial tree in HTAD with known distal vasculature involvement and justify closer follow-up and earlier surgical intervention in HTAD with high risk of dissection of minimal or normal aortic size. Evolving phenotype–genotype correlations lead us towards more precise and individualized management and treatment of patients with HTAD. In this review, we present the latest evidence regarding the role of genetics in patients with HTAD.

Highlights

  • Genetics of Heritable Thoracic AorticOver the last two decades, genetic developments have significantly improved our understanding of heritable thoracic aortic disease (HTAD)

  • Syndromic HTAD typically exhibits a multiorgan phenotype and is caused by genetic variants that are involved in the transforming growth factor-β (TGF-β) pathway and genes encoding extracellular matrix proteins [2]

  • Despite a greater frequency of surgery and type B aortic dissections in Marfan syndrome (MFS) patients harboring Haploinsufficient FBN1 variants (HI-FBN1) variants, all type A dissections that occurred at an aortic root diameter

Read more

Summary

Introduction

Over the last two decades, genetic developments have significantly improved our understanding of heritable thoracic aortic disease (HTAD). The identification of new syndromes [1] and novel candidate genes [2] has changed the paradigm in the diagnostic evaluation of these patients. Specific genotype–phenotype correlations continue to emerge, promising a more precise and effective approach in the treatment of HTAD [3,4,5]. The goal of this review is to inform clinicians about the value and effect of genetics in the diagnosis, management, surveillance, risk stratification and familial evaluation of patients with HTAD. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

Classification
Diagnostic Workup
Marfan Syndrome
Loeys–Dietz Syndrome
Rare Syndromic HTAD
Filamin A-Related HTAD
LOX-Related HTAD
LTBP3-Related HTAD
ACTA2-Related sHTAD
Thoracic Aortic Disease in Metabolic Storage Disease
Bicuspid Aortic Valve Related HTAD
Familial and Sporadic Nonsyndromic HTAD
Genetic Testing and Surgical Intervention
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call